Safe and Efficacious Near Superhydrophobic Hemostat for Reduced Blood Loss and Easy Detachment in Traumatic Wounds
Source abstract
Abstract
Hemorrhage is the leading cause of trauma death, and innovation in hemostatic technology is important. The strongly hydrophobic carbon nanofiber (CNF) coating has previously been shown to have excellent hemostatic properties. However, the understanding of how CNF coating guides the coagulation cascade and the biosafety of CNF as hemostatic agents has yet to be explored. Here, our thrombin generation assay investigation showed that CNF induced fast blood coagulation via factor (F) XII activation of the intrinsic pathway. We further performed studies of a rat vein injury and demonstrated that the CNF gauze enabled a substantial reduction of blood loss compared to both the plain gauze and kaolin-imbued gauze (QuikClot). Analysis of blood samples from the model revealed no acute toxicity from the CNF gauze, with no detectable CNF deposition in any organ, suggesting that the immobilization of CNF on our gauze prevented the infiltration of CNF into the bloodstream. Direct injection of CNF into the rat vein was also investigated and found not to elicit overt acute toxicity or affect animal survival or behavior. Finally, toxicity assays with primary keratinocytes revealed minimal toxicity responses to CNF. Our studies thus supported the safety and efficacy of the CNF hemostatic gauze, highlighting its potential as a promising approach in the field of hemostatic control.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemostasis and retained surgical items · Trauma, Hemostasis, Coagulopathy, Resuscitation · Blood properties and coagulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, National University of Singapore, Singapore 117583, Singapore
Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom
National Heart and Lung Institute, Imperial College London, London SW3 6LY, United Kingdom
Department of Immunology and Inflammation, Imperial College London, London W12 0NN, United Kingdom
Funding
Imperial College London · National University of Singapore
References (43)
Show source-provided references
1. American Association for the Surgery of Trauma (AAST). Trauma Facts; AAST: Chicago, IL, 2023.
2. World Health Organization (WHO). Road Safety; WHO: Geneva, Switzerland, 2020.
3. The World Bank Battle-Related Deaths (Number of People); The World Bank: Washington, D.C., 2022; https://data.worldbank.org/indicator/VC.BTL.DETH.
4. 10.1093/occmed/kqx06810.1093/occmed/kqx068 ↗
5. 10.1097/TA.0b013e318221147b10.1097/TA.0b013e318221147b ↗
6. 10.7205/MILMED.169.12S.810.7205/MILMED.169.12S.8 ↗
7. 10.1097/01.ta.0000199961.02677.1910.1097/01.ta.0000199961.02677.19 ↗
8. 10.1097/TA.0b013e3182755dcc10.1097/TA.0b013e3182755dcc ↗
9. 10.1097/SLA.000000000000299910.1097/SLA.0000000000002999 ↗
10. 10.1111/j.1742-4801.2006.00215.x10.1111/j.1742-4801.2006.00215.x ↗
11. 10.1038/s41467-019-13512-810.1038/s41467-019-13512-8 ↗
12. 10.1021/acsami.2c0887010.1021/acsami.2c08870 ↗
13. 10.1021/acsami.7b0776910.1021/acsami.7b07769 ↗
14. 10.1021/acsami.1c2466810.1021/acsami.1c24668 ↗
15. 10.1021/acsami.1c1089110.1021/acsami.1c10891 ↗
16. 10.1016/j.jss.2020.12.04010.1016/j.jss.2020.12.040 ↗
17. 10.1021/acsami.6b1330210.1021/acsami.6b13302 ↗
18. 10.1038/s41467-019-13512-810.1038/s41467-019-13512-8 ↗
19. 10.1002/admi.20210141210.1002/admi.202101412 ↗
20. 10.1177/146040860809126610.1177/1460408608091266 ↗
21. 10.2147/CEOR.S5900510.2147/CEOR.S59005 ↗
22. 10.1007/s10570-009-9377-y10.1007/s10570-009-9377-y ↗
23. 10.1182/blood-2012-05-43200510.1182/blood-2012-05-432005 ↗
24. 10.1182/blood-2010-11-31709910.1182/blood-2010-11-317099 ↗
25. 10.1016/j.biomaterials.2010.12.03310.1016/j.biomaterials.2010.12.033 ↗
26. 10.1038/s41598-018-37435-410.1038/s41598-018-37435-4 ↗
27. 10.1038/sj.onc.121013510.1038/sj.onc.1210135 ↗
28. 10.1038/s41598-021-04199-310.1038/s41598-021-04199-3 ↗
29. 10.1016/j.bbapap.2023.14093010.1016/j.bbapap.2023.140930 ↗
30. 10.1016/j.toxicon.2019.09.01010.1016/j.toxicon.2019.09.010 ↗
31. 10.1002/ame2.1204110.1002/ame2.12041 ↗
32. 10.1371/journal.pone.002203210.1371/journal.pone.0022032 ↗
33. 10.2147/IJN.S30805710.2147/IJN.S308057 ↗
34. 10.1021/acsami.0c1382510.1021/acsami.0c13825 ↗
35. 10.1039/C7CS00451F10.1039/C7CS00451F ↗
36. 10.1016/j.addr.2009.07.01010.1016/j.addr.2009.07.010 ↗
37. 10.1016/B978-0-12-396983-5.00019-310.1016/B978-0-12-396983-5.00019-3 ↗
38. 10.1016/B978-0-12-803581-8.00530-010.1016/B978-0-12-803581-8.00530-0 ↗
39. 10.3390/molecules2417316010.3390/molecules24173160 ↗
40. 10.1182/blood-2017-04-56911110.1182/blood-2017-04-569111 ↗
41. International Organization for Standardization (ISO). ISO 10993-5: Biological Evaluation of Medical Devices─Part 5: Tests for In Vitro Cytotoxicity; ISO: Geneva, Switzerland, 2009.
42. 10.1038/s41467-022-32222-210.1038/s41467-022-32222-2 ↗
43. 10.1111/j.1399-6576.2011.02406.x10.1111/j.1399-6576.2011.02406.x ↗